HCSG Earnings

HCSG reported its FY2025Q4 earnings on 2026-02-18, showcasing a revenue of against an estimate of 466.70M, resulting in a 0% surprise. The EPS was 0, surpassing the expected 0.23 by 0% . The stock experienced a 0% price change on the earnings day and a 0% change over the next five days, reflecting market reactions to the results.

Following HCSG's FY2025Q4 earnings announcement on 2026-02-18, the stock price moved by % on the day of the release. Over the subsequent five days, it saw a % change. Historically, HCSG's stock price tends to shift by an average of -4.54% in the 10 days leading up to earnings and +2.19% in the 10 days following, providing insight into potential market.

For 2025/Q4, analysts estimate HCSG’s annual revenue to reach 467.24M, while the EPS is projected at 0.23. These estimates reflect recent revisions, with revenue estimates revised Revenue No Change by -0% and EPS estimates No Change by 0% over the past three months, indicating analyst expectation in the company’s performance.

The correlation between HCSG's stock price and earnings forecast revisions shows that positive revisions in revenue or EPS often strengthen the stock’s fundamentals. Over the past three months, revenue estimates for FY2025 were No Change by -0%, while EPS estimates moved No Change by 0% . This trend suggests that price dips could present buying opportunities for investors.

Based on historical trends, HCSG's stock price typically moves by -4.54% in the 10 days before its earnings and +2.19% in the 10 days after. For the upcoming 2025/Q4 earnings, analysts expect an EPS of 0.23 and revenue of 467.24M.

The earnings call presents several positive factors: an 8.5% revenue increase, strong client retention, and promising cash flow. The company is optimistic about growth, with a strong client pipeline and strategic focus on cross-selling. While there are uncertainties regarding the OBBA allocation, labor market conditions are favorable. The share repurchase plan is a positive signal for shareholder returns. The Q&A session reinforced confidence in growth strategies, despite the lack of specifics on the OBBA. Overall, the sentiment leans positive, likely resulting in a 2% to 8% stock price increase.